Related Experiment Videos

Vaginal bleeding with multicystic ovaries and a pituitary mass in a child with severe hypothyroidism

F Mohsin1, N Nahar, K Azad

  • 1Department of Paediatrics, Bangladesh Institute of Research and Rehabilitation on Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka, Bangladesh. fauzia1971@dhaka.net

Insights

A young girl with hypothyroidism and precocious puberty experienced vaginal bleeding and an abdominal mass. Thyroxine treatment resolved these symptoms, including ovarian cysts and a pituitary mass.

Area of Science:

  • Pediatric Endocrinology
  • Reproductive Endocrinology
  • Neuroendocrinology

Background:

  • Precocious puberty and hypothyroidism can present with complex symptoms in children.
  • Pituitary macroadenomas can cause hormonal imbalances and mass effects.
  • Cyclic vaginal bleeding in a pre-pubertal child warrants thorough investigation.

Observation:

  • A 7-year-old girl presented with cyclic vaginal bleeding, a large abdominopelvic mass, and clinical signs of hypothyroidism.
  • Investigations confirmed primary hypothyroidism with precocious puberty, bilateral cystic ovarian enlargement, and a pituitary macroadenoma.
  • The patient exhibited symptoms suggestive of a potential link between hypothyroidism, precocious puberty, and pituitary pathology.

Findings:

  • Treatment with thyroxine normalized thyroid hormone levels (euthyroid state) and improved the patient's overall condition.
  • Thyroxine monotherapy effectively halted cyclic vaginal bleeding.
  • Ovarian cysts resolved rapidly, and the pituitary macroadenoma showed significant regression following thyroxine treatment.

Implications:

  • This case highlights the potential for hypothyroidism to manifest with symptoms of precocious puberty and significant gynecological and neurological findings.
  • Thyroxine replacement therapy can be a crucial intervention, potentially resolving multiple endocrine and structural abnormalities in such cases.
  • Early diagnosis and appropriate management of pediatric endocrine disorders are essential for preventing long-term complications.

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...